Salix Among National HBPA Convention Discussion Topics

The National Horsemen's Benevolent and Protective Association (HBPA) will tackle several issues, including the use of furosemide on race day during its winter convention Jan. 12-16 in Hollywood Beach, Fla.

Furosemide, known as Salix or Lasix, will be discussed Jan. 14 during the National HBPA Medication Committee forum. The organization said the "scientific case" for use of the drug to control exercise-induced pulmonary hemorrhaging (EIPH) will be the focus.

Use of the drug on race day was a high-priority industry issue in 2011. No racing regulatory body has yet taken action to ban furosemide on race day.

Panelists will be Steven Barker, MSc, PhD, chemist for the Louisiana State Racing Commission; Thomas Brokken, DVM, a long-time racetrack veterinarian; Mark Dedomenico, MD, a heart surgeon who owns Eclipse Award winner Blind Luck; and Thomas Tobin, MVB, MSc, PhD, MRCVS, DABT, a professor at the University of Kentucky's Gluck Equine Research Center and the National HBPA veterinary adviser.

Related Content:

About the Author

Tom LaMarra

Tom LaMarra, a native of New Jersey and graduate of Rutgers University, has been news editor at The Blood-Horse since 1998. After graduation he worked at newspapers in New Jersey and Pennsylvania as an editor and reporter with a focus on municipal government and politics. He also worked at Daily Racing Form and Thoroughbred Times before joining The Blood-Horse. LaMarra, who has lived in Lexington since 1994, has won various writing awards and was recognized with the Old Hilltop Award for outstanding coverage of the horse racing industry. He likes to spend some of his spare time handicapping races.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from Learn More